The following stocks have been highlighted by analysts or screens as having high-risk, high-reward potential. : ~$0.49
: Maintained as a "Moderate Buy" by consensus, with significant upside price targets based on its genetic pipeline. Plus Therapeutics (PSTV) : ~$0.25 stocks under $1 to buy
Investing in sub-$1 stocks is generally considered speculative rather than a traditional "long-term buy and hold" strategy due to these factors: The following stocks have been highlighted by analysts